GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EPS (Diluted)

Notable Labs (Notable Labs) EPS (Diluted) : $ (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs EPS (Diluted)?

Notable Labs's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was $-3.41.

Notable Labs's EPS (Basic) for the six months ended in Dec. 2023 was $-3.41.

Notable Labs's EPS without NRI for the six months ended in Dec. 2023 was $-4.91.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Notable Labs EPS (Diluted) Historical Data

The historical data trend for Notable Labs's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs EPS (Diluted) Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
EPS (Diluted)
-1.80 -1.61 -3.41

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
EPS (Diluted) -1.80 -1.61 -3.41

Competitive Comparison of Notable Labs's EPS (Diluted)

For the Biotechnology subindustry, Notable Labs's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's PE Ratio distribution charts can be found below:

* The bar in red indicates where Notable Labs's PE Ratio falls into.


Notable Labs EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Notable Labs's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-11.264-0)/3.303
=-3.41

Notable Labs's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-11.264-0)/3.303
=-3.41

Notable Labs  (NAS:NTBL) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Notable Labs EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Notable Labs's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EPS (Diluted)
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.